Analysts fell to the sidelines weighing in on Seagen (SGEN – Research Report), Crispr Therapeutics AG (CRSP – Research Report) and Merck & Company (MRK – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Seagen (SGEN)
In a report issued on July 29, Kennen MacKay from RBC Capital maintained a Hold rating on Seagen, with a price target of $148.00. The company’s shares closed last Friday at $153.39.
According to TipRanks.com, MacKay is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Seagen with a $187.00 average price target, which is a 23.0% upside from current levels. In a report issued on July 16, Morgan Stanley also maintained a Hold rating on the stock with a $167.00 price target.
See today’s analyst top recommended stocks >>
Crispr Therapeutics AG (CRSP)
RBC Capital analyst Luca Issi maintained a Hold rating on Crispr Therapeutics AG on July 30 and set a price target of $117.00. The company’s shares closed last Friday at $121.02.
According to TipRanks.com, Issi is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Crispr Therapeutics AG is a Moderate Buy with an average price target of $163.22, representing a 33.3% upside. In a report issued on July 30, Stifel Nicolaus also maintained a Hold rating on the stock with a $139.00 price target.
Merck & Company (MRK)
In a report issued on July 29, Daniel Busby from RBC Capital maintained a Hold rating on Merck & Company, with a price target of $80.00. The company’s shares closed last Friday at $76.87.
According to TipRanks.com, Busby is a 1-star analyst with an average return of
Merck & Company has an analyst consensus of Moderate Buy, with a price target consensus of $93.57.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SGEN:
- Wall Street Analysts Are Bullish on Top Technology Picks
- Analysts Conflicted on These Conglomerates Names: Norfolk Southern (NSC), IDEX (IEX) and Fortune Brands (FBHS)
- Analysts Offer Insights on Materials Companies: Sherwin-Williams Company (SHW), West Fraser Timber Co (WFG) and Enviva (EVA)
- Analysts Offer Insights on Financial Companies: S&P Global (SPGI), Mastercard (MA) and Camden Property (CPT)
- Analysts Offer Insights on Consumer Goods Companies: Shopify (SHOP), Procter & Gamble (PG) and Nestlé SA (OtherNSRGF)